My calculations for Q3FY19 have Lifx revenue as A$8.219m (71% growth).
Q3FY19: Total Revenue A$8.750m = BUD A$0.531m, LIFX A$8.219mQ3FY18: Total Revenue A$5.302m = BUD A$0.505m, LIFX A$4.797m
- Forums
- ASX - By Stock
- BUD
- Ann: Appendix 4C - Quarterly Report with commentary
Ann: Appendix 4C - Quarterly Report with commentary, page-196
-
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BUD (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online